MilliporeSigma is investing $65 million to expand its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, WI. The investment will allow large-scale manufacturing of increasingly potent compounds that have the potential to treat cancer. Completion is expected by mid-2022 and should add approximately 50 full-time jobs starting in 2021.   The new 70,000-square-foot commercial building will be one of the largest dedicated HPAPI manufacturing facilities specifically ...